Baum Alex E MD - 70112 New Orleans, LA

Business Name: Baum Alex E MD
Categorized In: Internal Medicine Doctors
Address: 1415 Tulane Avenue, New Orleans, LA 70112
Phone Number: (504) 988-5800
Contact Person: Alex Baum
Website Address: myprostatecancer.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2011
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Marc Jeffery Kahn - New Orleans, LA 70112
Leissinger Cindy Anne MD - New Orleans, LA 70112
Ricciardi James E MD - New Orleans, LA 70112
Rodenhauser Paul MD - New Orleans, LA 70112
Newman Alan W MD - New Orleans, LA 70112
Billens-Ivory Susan MD - New Orleans, LA 70112
Connelly Stephanie MD - New Orleans, LA 70112
Griffin Phillip T MD - New Orleans, LA 70112
Newsome R Edward MD - New Orleans, LA 70112
Kuske Robert R MD - New Orleans, LA 70112
Pacheco Hector MD - New Orleans, LA 70112
Eckert R Christa MD - New Orleans, LA 70112
Hoffman V Lee - New Orleans, LA 70112
Andersson Hans MD - New Orleans, LA 70112
Richardson Donald E MD - New Orleans, LA 70112
Daniel P Shepard - New Orleans, LA 70112
Pullen Bailey P PhD - New Orleans, LA 70112
Michael F Mascia - New Orleans, LA 70112
Jeff Wiese - New Orleans, LA 70112
Barnes Steven MD - New Orleans, LA 70112

Baum Alex E MD provides professional Internal Medicine Doctors from its single location at the coordinates 29.955439,-90.07632.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 2011, the company can now be visited at 1415 Tulane Avenue, New Orleans, Louisiana 70112 or contacted through representative Alex Baum at (504) 988-5800.

For frequently asked questions and further inquiries about professional Internal Medicine Doctors, get to know more about Baum Alex E MD through its company website at myprostatecancer.com. Engage with this business on its social media platforms through on Twitter and on Facebook.